Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox8
|
ENSMUSG00000024176.4 | SRY (sex determining region Y)-box 8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_25567328_25567543 | Sox8 | 2779 | 0.115348 | 0.68 | 1.2e-08 | Click! |
chr17_25567941_25568135 | Sox8 | 2176 | 0.135763 | 0.60 | 1.2e-06 | Click! |
chr17_25568205_25568416 | Sox8 | 1904 | 0.150531 | 0.56 | 7.4e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_8509688_8509990 | 31.00 |
Stmn2 |
stathmin-like 2 |
253 |
0.93 |
chr5_20748236_20748446 | 30.82 |
1110060G06Rik |
RIKEN cDNA 1110060G06 gene |
19947 |
0.17 |
chr9_36881381_36881946 | 27.89 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
11160 |
0.19 |
chr11_42000451_42000692 | 27.79 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
39 |
0.99 |
chr14_13198578_13198745 | 27.57 |
Gm5087 |
predicted gene 5087 |
27759 |
0.23 |
chr8_70118830_70119054 | 27.41 |
Ncan |
neurocan |
1931 |
0.15 |
chr16_34395247_34395418 | 27.31 |
Kalrn |
kalirin, RhoGEF kinase |
3223 |
0.39 |
chr8_69161317_69161515 | 26.88 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
20463 |
0.15 |
chr12_98563216_98563398 | 26.87 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
11405 |
0.14 |
chr6_54554355_54554906 | 24.97 |
Scrn1 |
secernin 1 |
175 |
0.95 |
chr4_45830463_45830661 | 24.70 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
3639 |
0.19 |
chr2_22029338_22029851 | 24.59 |
Gm13337 |
predicted gene 13337 |
38232 |
0.22 |
chr13_84783651_84783837 | 24.54 |
Gm26913 |
predicted gene, 26913 |
92803 |
0.09 |
chr2_94265944_94266142 | 24.32 |
Mir670hg |
MIR670 host gene (non-protein coding) |
1125 |
0.42 |
chr6_50777784_50778006 | 23.86 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
1571 |
0.34 |
chr5_120365955_120366154 | 23.65 |
Gm42654 |
predicted gene 42654 |
20086 |
0.15 |
chr1_92737945_92738245 | 23.59 |
Gm29483 |
predicted gene 29483 |
20893 |
0.12 |
chr16_33605736_33606716 | 22.86 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr3_127749245_127749655 | 22.73 |
Gm23279 |
predicted gene, 23279 |
17856 |
0.1 |
chr17_73507966_73508157 | 22.49 |
AC107792.1 |
Novel transcript |
9694 |
0.17 |
chr4_45823240_45823441 | 22.36 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
3583 |
0.19 |
chr8_15949900_15950086 | 21.99 |
Csmd1 |
CUB and Sushi multiple domains 1 |
34819 |
0.21 |
chr7_97804643_97804853 | 21.80 |
Pak1 |
p21 (RAC1) activated kinase 1 |
16207 |
0.19 |
chr7_51749835_51750061 | 21.66 |
Gm7336 |
predicted gene 7336 |
3301 |
0.23 |
chr5_139892641_139892972 | 21.53 |
Gm42423 |
predicted gene 42423 |
3003 |
0.21 |
chr14_100720698_100720869 | 21.48 |
Gm22401 |
predicted gene, 22401 |
20162 |
0.2 |
chr4_81567754_81568245 | 20.65 |
Gm11765 |
predicted gene 11765 |
106267 |
0.07 |
chr14_13651882_13652062 | 20.55 |
Sntn |
sentan, cilia apical structure protein |
18904 |
0.24 |
chr14_108910528_108910794 | 20.34 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
3497 |
0.39 |
chr11_42654307_42654494 | 20.33 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
233050 |
0.02 |
chr1_92733907_92734080 | 20.31 |
Gm29483 |
predicted gene 29483 |
16791 |
0.13 |
chr8_6207539_6207933 | 20.27 |
Gm44842 |
predicted gene 44842 |
10932 |
0.24 |
chr13_99442367_99442533 | 20.05 |
Map1b |
microtubule-associated protein 1B |
1494 |
0.4 |
chr8_69161565_69161757 | 19.97 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
20569 |
0.15 |
chr13_83742140_83742347 | 19.92 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3380 |
0.15 |
chr14_68197161_68197356 | 19.89 |
Gm47212 |
predicted gene, 47212 |
20995 |
0.18 |
chr10_96308993_96309463 | 19.77 |
Gm48427 |
predicted gene, 48427 |
117 |
0.92 |
chr8_37291540_37291737 | 19.72 |
Gm25126 |
predicted gene, 25126 |
25940 |
0.16 |
chr7_73917720_73918558 | 19.50 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr15_88978956_88979127 | 19.46 |
Mlc1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human) |
34 |
0.95 |
chr2_93957591_93957803 | 19.34 |
Gm13889 |
predicted gene 13889 |
496 |
0.74 |
chr4_72382561_72382773 | 19.22 |
Gm11235 |
predicted gene 11235 |
159999 |
0.04 |
chr4_97648937_97649212 | 18.89 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
41662 |
0.18 |
chr16_52600931_52601082 | 18.87 |
Gm49634 |
predicted gene, 49634 |
19598 |
0.28 |
chr2_46242890_46243089 | 18.74 |
Gm23072 |
predicted gene, 23072 |
63347 |
0.15 |
chr13_84059669_84060031 | 18.73 |
Gm17750 |
predicted gene, 17750 |
4922 |
0.24 |
chr12_26877757_26878194 | 18.68 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
43102 |
0.2 |
chr10_106609605_106610022 | 18.49 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
7333 |
0.29 |
chr19_26844786_26845745 | 18.32 |
4931403E22Rik |
RIKEN cDNA 4931403E22 gene |
21358 |
0.18 |
chr1_54707946_54708132 | 18.17 |
Ankrd44 |
ankyrin repeat domain 44 |
15037 |
0.16 |
chr10_37378009_37378297 | 18.12 |
Gm26535 |
predicted gene, 26535 |
40667 |
0.19 |
chr8_108535556_108535800 | 17.88 |
Gm39244 |
predicted gene, 39244 |
1269 |
0.56 |
chr2_49718537_49718899 | 17.87 |
Kif5c |
kinesin family member 5C |
3849 |
0.28 |
chr10_20723138_20723443 | 17.51 |
Pde7b |
phosphodiesterase 7B |
1406 |
0.48 |
chr12_27670674_27670825 | 17.45 |
Gm24326 |
predicted gene, 24326 |
38946 |
0.2 |
chr13_51569697_51570174 | 17.43 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
448 |
0.86 |
chr13_70714446_70714610 | 17.37 |
Gm36607 |
predicted gene, 36607 |
8295 |
0.19 |
chr7_75868535_75868959 | 17.33 |
Klhl25 |
kelch-like 25 |
20306 |
0.21 |
chr8_29543927_29544189 | 17.02 |
Nudc-ps1 |
nuclear distribution gene C homolog (Aspergillus), pseudogene 1 |
257077 |
0.02 |
chr4_100913798_100913949 | 16.94 |
Cachd1 |
cache domain containing 1 |
80738 |
0.09 |
chr13_58964694_58965094 | 16.94 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
93159 |
0.06 |
chr3_5415175_5415350 | 16.86 |
4930555M17Rik |
RIKEN cDNA 4930555M17 gene |
100071 |
0.08 |
chr11_14520710_14520861 | 16.85 |
Gm12006 |
predicted gene 12006 |
33172 |
0.2 |
chr11_31845447_31845702 | 16.74 |
Gm12107 |
predicted gene 12107 |
12914 |
0.18 |
chr6_58932915_58933165 | 16.73 |
Herc3 |
hect domain and RLD 3 |
25778 |
0.12 |
chr3_54965592_54965792 | 16.71 |
Sertm1 |
serine rich and transmembrane domain containing 1 |
49805 |
0.12 |
chr16_64333210_64333373 | 16.69 |
Csnka2ip |
casein kinase 2, alpha prime interacting protein |
145857 |
0.05 |
chr13_8995529_8996265 | 16.67 |
Gtpbp4 |
GTP binding protein 4 |
153 |
0.91 |
chr9_45651665_45651844 | 16.65 |
Gm22069 |
predicted gene, 22069 |
16942 |
0.18 |
chr7_16959904_16960115 | 16.56 |
Pnmal1 |
PNMA-like 1 |
330 |
0.77 |
chr15_85458876_85459086 | 16.42 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
44246 |
0.13 |
chr7_56598360_56598512 | 16.41 |
Gm44979 |
predicted gene 44979 |
149838 |
0.04 |
chr18_27542508_27542806 | 16.39 |
Gm7729 |
predicted gene 7729 |
55987 |
0.17 |
chr12_46707467_46707817 | 16.37 |
Gm33869 |
predicted gene, 33869 |
3426 |
0.18 |
chr9_13246797_13247848 | 16.36 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr1_63828562_63828745 | 16.30 |
Gm13751 |
predicted gene 13751 |
16925 |
0.19 |
chr6_22794011_22794374 | 16.27 |
Gm25942 |
predicted gene, 25942 |
4374 |
0.18 |
chr8_12207665_12207816 | 16.26 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
71079 |
0.09 |
chr1_34664681_34665051 | 16.20 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
13322 |
0.12 |
chr2_49571896_49572047 | 16.15 |
Epc2 |
enhancer of polycomb homolog 2 |
43096 |
0.16 |
chr11_6597201_6597589 | 16.13 |
Nacad |
NAC alpha domain containing |
1997 |
0.16 |
chr10_106975829_106976048 | 16.09 |
Gm19007 |
predicted gene, 19007 |
26641 |
0.2 |
chr6_6163092_6163256 | 16.02 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
10777 |
0.26 |
chr1_169051510_169051841 | 16.02 |
Mir6354 |
microRNA 6354 |
32586 |
0.25 |
chr16_22438471_22438689 | 15.97 |
Etv5 |
ets variant 5 |
990 |
0.55 |
chr8_32959326_32959711 | 15.95 |
Gm3985 |
predicted gene 3985 |
9492 |
0.28 |
chr7_89035231_89035388 | 15.91 |
Tmem135 |
transmembrane protein 135 |
110188 |
0.06 |
chr3_68072068_68072422 | 15.90 |
Schip1 |
schwannomin interacting protein 1 |
7443 |
0.3 |
chr17_65700141_65700311 | 15.87 |
Gm49867 |
predicted gene, 49867 |
38648 |
0.13 |
chr1_67366181_67366412 | 15.71 |
Gm26342 |
predicted gene, 26342 |
109072 |
0.06 |
chr5_85239463_85240008 | 15.68 |
Gm21006 |
predicted gene, 21006 |
372890 |
0.01 |
chr7_76185386_76185573 | 15.61 |
Agbl1 |
ATP/GTP binding protein-like 1 |
44408 |
0.17 |
chr3_105569533_105569784 | 15.59 |
Gm43847 |
predicted gene 43847 |
66751 |
0.09 |
chr14_47890672_47890828 | 15.54 |
4930447J18Rik |
RIKEN cDNA 4930447J18 gene |
8101 |
0.19 |
chr16_90353067_90353277 | 15.53 |
Gm49708 |
predicted gene, 49708 |
3530 |
0.17 |
chr3_4546148_4546485 | 15.39 |
Gm22944 |
predicted gene, 22944 |
21019 |
0.21 |
chr13_113587190_113587829 | 15.38 |
Gm34471 |
predicted gene, 34471 |
19742 |
0.15 |
chr10_17238117_17238268 | 15.37 |
Gm47761 |
predicted gene, 47761 |
83419 |
0.09 |
chr2_142980883_142981063 | 15.34 |
Kif16bos |
kinesin family member 16B, opposite strand |
78008 |
0.09 |
chr13_97823915_97824432 | 15.33 |
Gm41031 |
predicted gene, 41031 |
1712 |
0.35 |
chr5_98976230_98976410 | 15.16 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
9564 |
0.25 |
chr1_52306256_52306626 | 15.15 |
Gm5975 |
predicted gene 5975 |
17346 |
0.21 |
chr17_60267150_60267583 | 15.12 |
Gm29051 |
predicted gene 29051 |
136491 |
0.05 |
chr12_68862767_68862920 | 15.01 |
Gm47491 |
predicted gene, 47491 |
50546 |
0.14 |
chr12_50538426_50538588 | 14.86 |
Prkd1 |
protein kinase D1 |
110591 |
0.07 |
chr12_75177736_75177914 | 14.76 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
493 |
0.88 |
chr8_86961747_86962117 | 14.75 |
Gm24781 |
predicted gene, 24781 |
3687 |
0.2 |
chr5_131531798_131531960 | 14.74 |
Auts2 |
autism susceptibility candidate 2 |
2518 |
0.28 |
chr18_74956461_74956661 | 14.74 |
Lipg |
lipase, endothelial |
4701 |
0.11 |
chr6_8956269_8957017 | 14.73 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr13_28416227_28416775 | 14.71 |
Gm40841 |
predicted gene, 40841 |
3362 |
0.31 |
chr12_12684977_12685317 | 14.70 |
Gm27952 |
predicted gene, 27952 |
2529 |
0.25 |
chr10_13415790_13416203 | 14.64 |
Phactr2 |
phosphatase and actin regulator 2 |
27026 |
0.21 |
chr3_5755500_5755721 | 14.63 |
Gm8797 |
predicted pseudogene 8797 |
4804 |
0.31 |
chr11_35537591_35537750 | 14.60 |
Slit3 |
slit guidance ligand 3 |
7015 |
0.28 |
chr13_84448589_84449243 | 14.59 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr13_93510963_93511207 | 14.45 |
Jmy |
junction-mediating and regulatory protein |
11277 |
0.18 |
chr4_22478018_22478185 | 14.40 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
10265 |
0.17 |
chr17_50954395_50954624 | 14.37 |
Tbc1d5 |
TBC1 domain family, member 5 |
30117 |
0.21 |
chr3_127293621_127294038 | 14.33 |
Gm42970 |
predicted gene 42970 |
5844 |
0.15 |
chr2_124720858_124721009 | 14.29 |
Gm13994 |
predicted gene 13994 |
12278 |
0.28 |
chr15_32433868_32434019 | 14.27 |
Sema5a |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
167732 |
0.03 |
chr14_86441996_86442147 | 14.26 |
Gm32913 |
predicted gene, 32913 |
32972 |
0.14 |
chr4_111443852_111444203 | 14.13 |
Bend5 |
BEN domain containing 5 |
10708 |
0.22 |
chr8_55026049_55026477 | 14.11 |
Gm45264 |
predicted gene 45264 |
2138 |
0.23 |
chr13_20609411_20609562 | 14.10 |
Gm47721 |
predicted gene, 47721 |
36271 |
0.17 |
chr12_118650884_118651200 | 14.07 |
Gm9267 |
predicted gene 9267 |
48365 |
0.15 |
chrX_71700854_71701085 | 14.05 |
Gm14723 |
predicted gene 14723 |
26688 |
0.18 |
chr3_89559332_89559497 | 14.02 |
Kcnn3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
39250 |
0.12 |
chr8_90209533_90209684 | 14.01 |
Tox3 |
TOX high mobility group box family member 3 |
138518 |
0.05 |
chr3_105531449_105531651 | 14.00 |
Gm43847 |
predicted gene 43847 |
28643 |
0.18 |
chr11_33843303_33843965 | 13.95 |
Kcnip1 |
Kv channel-interacting protein 1 |
49 |
0.99 |
chr10_70520228_70520499 | 13.95 |
Gm29783 |
predicted gene, 29783 |
15115 |
0.22 |
chrX_143543266_143543620 | 13.85 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr17_69970304_69970690 | 13.85 |
Dlgap1 |
DLG associated protein 1 |
1076 |
0.59 |
chr6_51656173_51656324 | 13.85 |
Gm22914 |
predicted gene, 22914 |
34616 |
0.17 |
chr3_79416721_79416872 | 13.84 |
Fnip2 |
folliculin interacting protein 2 |
49409 |
0.13 |
chr8_48224421_48225088 | 13.82 |
Gm32842 |
predicted gene, 32842 |
46231 |
0.16 |
chr5_16134186_16134593 | 13.79 |
Gm43490 |
predicted gene 43490 |
27260 |
0.22 |
chr4_7997658_7997876 | 13.72 |
Gm11800 |
predicted gene 11800 |
120853 |
0.06 |
chr1_66402006_66402157 | 13.72 |
Map2 |
microtubule-associated protein 2 |
13180 |
0.19 |
chr18_46638401_46638644 | 13.65 |
Gm3734 |
predicted gene 3734 |
7715 |
0.16 |
chr3_57789672_57789843 | 13.63 |
Rnf13 |
ring finger protein 13 |
11048 |
0.14 |
chr18_34107370_34107560 | 13.63 |
Gm24432 |
predicted gene, 24432 |
14020 |
0.15 |
chr19_41190963_41191114 | 13.62 |
Tll2 |
tolloid-like 2 |
15736 |
0.23 |
chr1_43006095_43006311 | 13.57 |
Gpr45 |
G protein-coupled receptor 45 |
25857 |
0.14 |
chr14_24550971_24551440 | 13.57 |
Rps24 |
ribosomal protein S24 |
60056 |
0.09 |
chr11_25156710_25156955 | 13.53 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
75794 |
0.11 |
chr1_11657743_11658030 | 13.47 |
Gm38069 |
predicted gene, 38069 |
46321 |
0.15 |
chr1_5232314_5232482 | 13.42 |
Gm7182 |
predicted gene 7182 |
44939 |
0.16 |
chr18_43619433_43619779 | 13.41 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
45361 |
0.14 |
chr15_103519338_103519794 | 13.38 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4152 |
0.16 |
chr2_172270517_172270695 | 13.36 |
Gm14275 |
predicted gene 14275 |
17527 |
0.15 |
chr6_91843747_91844084 | 13.28 |
Grip2 |
glutamate receptor interacting protein 2 |
16665 |
0.14 |
chr15_32172294_32172456 | 13.24 |
Tas2r119 |
taste receptor, type 2, member 119 |
4914 |
0.24 |
chr5_120206405_120206569 | 13.23 |
Rbm19 |
RNA binding motif protein 19 |
30762 |
0.15 |
chr9_75683708_75684585 | 13.13 |
Scg3 |
secretogranin III |
90 |
0.96 |
chr3_129640268_129640581 | 13.12 |
Egf |
epidermal growth factor |
41122 |
0.12 |
chr7_18942456_18942756 | 13.09 |
Nova2 |
NOVA alternative splicing regulator 2 |
16718 |
0.08 |
chr5_40697632_40697798 | 13.07 |
Gm23022 |
predicted gene, 23022 |
291786 |
0.01 |
chr4_111597201_111597750 | 13.06 |
Agbl4 |
ATP/GTP binding protein-like 4 |
30750 |
0.22 |
chr5_25652707_25652858 | 12.93 |
Gm43972 |
predicted gene, 43972 |
7027 |
0.15 |
chr9_41697271_41698297 | 12.89 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr4_13778918_13779099 | 12.88 |
Runx1t1 |
RUNX1 translocation partner 1 |
5774 |
0.32 |
chr5_140659637_140660247 | 12.79 |
Iqce |
IQ motif containing E |
6299 |
0.15 |
chr9_15732190_15732374 | 12.72 |
Slc36a4 |
solute carrier family 36 (proton/amino acid symporter), member 4 |
5394 |
0.22 |
chr11_65928209_65928360 | 12.68 |
Dnah9 |
dynein, axonemal, heavy chain 9 |
326 |
0.94 |
chr13_26576225_26576399 | 12.66 |
Gm11353 |
predicted gene 11353 |
83758 |
0.09 |
chr8_33747412_33747586 | 12.65 |
Smim18 |
small integral membrane protein 18 |
271 |
0.88 |
chr8_34326259_34326892 | 12.63 |
Gm4889 |
predicted gene 4889 |
1335 |
0.32 |
chr10_42833999_42834609 | 12.63 |
Gm26464 |
predicted gene, 26464 |
13537 |
0.13 |
chr10_112203584_112203748 | 12.56 |
Gm47419 |
predicted gene, 47419 |
27475 |
0.13 |
chr4_10974474_10974681 | 12.55 |
Rps11-ps3 |
ribosomal protein S11, pseudogene 3 |
27969 |
0.14 |
chr5_18292776_18292962 | 12.52 |
Gm3527 |
predicted gene 3527 |
57479 |
0.15 |
chr2_49672278_49672906 | 12.51 |
Gm13525 |
predicted gene 13525 |
7907 |
0.24 |
chr9_67795202_67795353 | 12.46 |
M5C1000I18Rik |
RIKEN cDNA M5C1000I18 gene |
35047 |
0.11 |
chr9_103657277_103657528 | 12.46 |
Tmem108 |
transmembrane protein 108 |
35405 |
0.15 |
chr14_95877129_95877467 | 12.45 |
Spertl |
spermatid associated like |
3956 |
0.31 |
chr9_84278752_84279064 | 12.44 |
Gm26146 |
predicted gene, 26146 |
90553 |
0.08 |
chr5_5135037_5135401 | 12.38 |
Gm43623 |
predicted gene 43623 |
4888 |
0.21 |
chr14_46885106_46885668 | 12.36 |
2810457G06Rik |
RIKEN cDNA 2810457G06 gene |
323 |
0.74 |
chr16_77787854_77788233 | 12.36 |
Gm17333 |
predicted gene, 17333 |
58561 |
0.11 |
chr3_57846047_57846216 | 12.34 |
Pfn2 |
profilin 2 |
253 |
0.91 |
chr15_57162413_57162847 | 12.34 |
Gm26178 |
predicted gene, 26178 |
76483 |
0.11 |
chr10_71476582_71476795 | 12.33 |
Gm46233 |
predicted gene, 46233 |
6393 |
0.16 |
chr1_172329252_172329450 | 12.32 |
Kcnj9 |
potassium inwardly-rectifying channel, subfamily J, member 9 |
33 |
0.95 |
chr5_109554227_109554566 | 12.32 |
Gm8493 |
predicted gene 8493 |
240 |
0.89 |
chr12_38450330_38450718 | 12.30 |
Gm18338 |
predicted gene, 18338 |
81294 |
0.11 |
chr13_98497069_98497230 | 12.26 |
Gm10320 |
predicted pseudogene 10320 |
5148 |
0.15 |
chr15_30173371_30173555 | 12.19 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
325 |
0.93 |
chr8_99416428_99416802 | 12.19 |
A330008L17Rik |
RIKEN cDNA A330008L17 gene |
27 |
0.64 |
chr6_55520338_55520536 | 12.18 |
Gm44352 |
predicted gene, 44352 |
13069 |
0.23 |
chr6_140946871_140947164 | 12.15 |
Gm30524 |
predicted gene, 30524 |
8592 |
0.26 |
chr18_72637329_72637514 | 12.14 |
Gm31819 |
predicted gene, 31819 |
87646 |
0.1 |
chr19_23401869_23402055 | 12.07 |
Gm50445 |
predicted gene, 50445 |
16381 |
0.18 |
chr5_89701420_89702410 | 12.03 |
Gm25758 |
predicted gene, 25758 |
126956 |
0.05 |
chr13_107541201_107541459 | 12.03 |
Gm32004 |
predicted gene, 32004 |
23993 |
0.2 |
chr14_69057480_69057771 | 11.98 |
Gm41192 |
predicted gene, 41192 |
27973 |
0.15 |
chr13_106562675_106562826 | 11.97 |
Dph3b-ps |
diphthamide biosynthesis 3, pseudogene |
15690 |
0.22 |
chr10_74387760_74387995 | 11.95 |
Pcdh15 |
protocadherin 15 |
2004 |
0.5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 34.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
4.8 | 14.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.2 | 12.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.8 | 11.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
3.7 | 29.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
3.7 | 11.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.3 | 9.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
3.0 | 14.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
2.8 | 8.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
2.7 | 8.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.7 | 13.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.6 | 7.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.5 | 7.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.5 | 7.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.5 | 9.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.5 | 12.3 | GO:0070842 | aggresome assembly(GO:0070842) |
2.4 | 14.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.3 | 4.5 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
2.3 | 6.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.2 | 11.1 | GO:0021764 | amygdala development(GO:0021764) |
2.2 | 6.5 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.1 | 8.3 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.0 | 6.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.0 | 6.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.9 | 5.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.9 | 7.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.9 | 7.4 | GO:0007296 | vitellogenesis(GO:0007296) |
1.8 | 16.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.8 | 1.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.8 | 5.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.7 | 6.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.7 | 5.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.6 | 4.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.6 | 4.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.6 | 9.6 | GO:0072017 | distal tubule development(GO:0072017) |
1.6 | 4.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.5 | 12.4 | GO:0071625 | vocalization behavior(GO:0071625) |
1.5 | 6.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.5 | 6.1 | GO:0060594 | mammary gland specification(GO:0060594) |
1.5 | 4.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.5 | 14.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.4 | 5.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.3 | 5.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.3 | 4.0 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.3 | 4.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.3 | 6.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.3 | 18.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.3 | 2.6 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.3 | 2.6 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
1.3 | 3.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.2 | 3.7 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.2 | 5.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.2 | 3.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.2 | 2.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.2 | 2.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.2 | 4.9 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.2 | 3.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 3.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.2 | 7.3 | GO:0022605 | oogenesis stage(GO:0022605) |
1.2 | 4.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.2 | 2.4 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.2 | 5.8 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.1 | 4.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.1 | 3.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.1 | 4.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.1 | 3.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.1 | 3.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.1 | 2.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.1 | 3.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.1 | 3.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.0 | 3.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.0 | 3.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
1.0 | 3.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.0 | 4.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.0 | 3.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.0 | 3.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.0 | 9.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.0 | 7.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.0 | 3.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.0 | 3.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.0 | 2.0 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.0 | 6.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.0 | 2.0 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.0 | 7.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.0 | 3.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.0 | 4.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 5.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.0 | 10.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.0 | 4.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 8.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.9 | 2.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.9 | 2.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.9 | 1.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.9 | 0.9 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.9 | 2.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.9 | 5.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.9 | 3.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 1.8 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 2.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.9 | 3.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.9 | 6.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.8 | 2.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.8 | 3.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.8 | 3.4 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.8 | 6.7 | GO:0032328 | alanine transport(GO:0032328) |
0.8 | 2.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.8 | 1.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.8 | 4.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 3.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 2.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.8 | 1.6 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.8 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.8 | 3.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.8 | 2.4 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.8 | 2.4 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 2.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.8 | 5.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 2.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.7 | 2.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 2.2 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.7 | 0.7 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.7 | 2.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.7 | 2.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.7 | 14.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.7 | 0.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.7 | 0.7 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.7 | 2.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 1.4 | GO:0098597 | vocal learning(GO:0042297) imitative learning(GO:0098596) observational learning(GO:0098597) learned vocalization behavior or vocal learning(GO:0098598) |
0.7 | 1.4 | GO:0021914 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 2.1 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 2.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.7 | 2.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.7 | 2.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.7 | 4.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.7 | 2.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.7 | 2.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.7 | 5.4 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.7 | 0.7 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.7 | 2.6 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.7 | 0.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.7 | 3.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.7 | 2.0 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.7 | 9.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.7 | 52.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 0.6 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.6 | 1.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.9 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.6 | 1.9 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 1.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 4.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.6 | 1.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.6 | 0.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 15.4 | GO:0007616 | long-term memory(GO:0007616) |
0.6 | 11.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.6 | 4.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.6 | 1.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 0.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 4.8 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.6 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 5.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 1.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 8.3 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.6 | 4.7 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.6 | 1.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 1.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.6 | 1.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.6 | 2.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.6 | 2.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 2.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.6 | 0.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 2.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.6 | 4.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.6 | 3.4 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.6 | 2.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.6 | 0.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.6 | 3.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.6 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 1.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 3.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.5 | 1.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.5 | 1.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.5 | 2.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 1.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.5 | 2.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 1.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.5 | 1.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 3.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.5 | 1.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.5 | 4.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 6.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 1.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 4.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 1.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.5 | 4.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.5 | 1.6 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 8.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 2.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 3.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.5 | 3.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.5 | 4.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.5 | 1.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.5 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 0.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 2.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.5 | 1.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.5 | 8.8 | GO:0001964 | startle response(GO:0001964) |
0.5 | 2.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 3.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.5 | 2.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 1.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.5 | 1.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 4.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 0.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 1.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 0.9 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 0.9 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.5 | 5.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.5 | 1.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.8 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.5 | 1.8 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.5 | 1.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 1.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.4 | 2.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 2.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.4 | 3.6 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.4 | 1.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 0.9 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.4 | 3.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 1.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 2.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 0.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 1.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 0.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 1.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 2.1 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 2.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 1.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 1.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.4 | 1.7 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.4 | 1.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 1.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 14.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 2.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 10.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 1.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 0.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.4 | 2.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.4 | 2.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 0.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 0.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.4 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.4 | 7.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 2.7 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 0.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 1.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.4 | 3.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 1.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 3.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 0.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 1.5 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 1.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 4.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.4 | 6.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.4 | 3.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.4 | 7.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 1.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.4 | 7.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 0.7 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.4 | 2.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.4 | 1.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 0.7 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 1.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 0.4 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 1.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.4 | 2.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 1.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.4 | 1.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 10.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.4 | 4.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 2.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.4 | 1.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 0.7 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.4 | 0.7 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.4 | 0.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.4 | 2.1 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.4 | 1.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 1.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 0.7 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.3 | 4.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 0.7 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 0.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.3 | 6.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 2.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 2.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 1.7 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.3 | 8.2 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 1.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 1.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.0 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 2.7 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 0.3 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 1.0 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 1.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 1.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 5.4 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 1.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.3 | 3.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 0.6 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.3 | 1.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.6 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 1.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 1.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.3 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 3.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.3 | 0.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 0.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 3.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 0.3 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.9 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.3 | 1.2 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.3 | 6.0 | GO:0007099 | centriole replication(GO:0007099) |
0.3 | 6.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 0.6 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 0.9 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.3 | 0.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 1.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 7.5 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.3 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 0.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.3 | 3.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.3 | 1.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.3 | 1.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 3.4 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.3 | 2.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 2.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.3 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 1.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 3.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 1.6 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 1.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 4.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 2.2 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.3 | 2.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 3.2 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.3 | 5.9 | GO:0021591 | ventricular system development(GO:0021591) |
0.3 | 1.6 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.3 | 1.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 1.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 1.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 3.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 1.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 1.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 0.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.3 | 0.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.3 | 0.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 7.4 | GO:0008542 | visual learning(GO:0008542) |
0.3 | 1.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 1.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 1.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 0.5 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 0.3 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 3.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.2 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.2 | 5.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 1.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 0.5 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.7 | GO:0042637 | catagen(GO:0042637) |
0.2 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 1.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 2.9 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.2 | 4.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 1.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.7 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 1.2 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.7 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 14.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.7 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.2 | 3.7 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.2 | 0.2 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 0.5 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.2 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 2.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.9 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.2 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 2.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 2.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 0.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.2 | 0.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 1.7 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 1.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 1.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.6 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 0.6 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 5.4 | GO:0021549 | cerebellum development(GO:0021549) |
0.2 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 1.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.9 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.2 | 1.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.2 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.2 | 0.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 3.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 3.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 0.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 1.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 1.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 1.0 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.7 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 1.6 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.2 | 0.6 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.2 | 0.5 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.2 | GO:0003128 | heart field specification(GO:0003128) |
0.2 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.6 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.8 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.6 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.9 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 1.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 1.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 3.5 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.1 | 1.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.8 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.4 | GO:0043584 | nose development(GO:0043584) |
0.1 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.7 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 1.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 1.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 2.5 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 1.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.6 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 2.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.5 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 2.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.4 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.3 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.4 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.2 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 1.4 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.4 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.4 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.6 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) cellular response to cocaine(GO:0071314) |
0.1 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.1 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) |
0.1 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.1 | 0.1 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.7 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.1 | 0.1 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.1 | 0.1 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.1 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.2 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.0 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.5 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.2 | GO:0035404 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0044766 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.3 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.2 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 0.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:2001055 | endothelial cell fate specification(GO:0060847) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.0 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.0 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.0 | 0.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.0 | 0.0 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 43.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.9 | 19.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.7 | 5.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.5 | 14.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.4 | 4.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.4 | 2.8 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.3 | 4.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.3 | 7.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.3 | 11.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.2 | 1.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.2 | 8.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.1 | 8.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.0 | 2.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 2.9 | GO:0043511 | inhibin complex(GO:0043511) |
0.9 | 3.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.9 | 5.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.8 | 3.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 6.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.8 | 3.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 3.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.8 | 2.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 3.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.8 | 3.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.8 | 1.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.8 | 2.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.8 | 9.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 4.5 | GO:0002177 | manchette(GO:0002177) |
0.7 | 3.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 5.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 2.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.7 | 2.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 44.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 4.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 2.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 30.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 3.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.7 | 8.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 3.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.7 | 4.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 17.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 1.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 4.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 1.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.6 | 2.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 4.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 9.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 5.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 1.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 2.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.5 | 7.2 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 18.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 1.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 1.4 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 1.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 3.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 2.2 | GO:0097433 | dense body(GO:0097433) |
0.4 | 7.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 60.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 3.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 2.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 10.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 4.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 5.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 4.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 43.6 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 3.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 1.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 1.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 0.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 15.4 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 8.0 | GO:0097060 | synaptic membrane(GO:0097060) |
0.4 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 3.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 3.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 6.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 1.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 19.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 1.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 4.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 4.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 1.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 4.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 3.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 0.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 3.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 5.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.7 | GO:0070187 | telosome(GO:0070187) |
0.2 | 1.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 2.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 2.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 1.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 8.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 1.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 11.1 | GO:0005901 | caveola(GO:0005901) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 4.7 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 2.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 2.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 2.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 6.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 10.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 2.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 3.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 8.0 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 2.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 2.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.0 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.9 | 11.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
3.5 | 10.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.2 | 9.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
3.0 | 11.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.8 | 16.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.7 | 13.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.4 | 14.2 | GO:0048495 | Roundabout binding(GO:0048495) |
2.3 | 11.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.3 | 42.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
2.2 | 8.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.2 | 6.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.1 | 6.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.8 | 7.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.8 | 7.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.8 | 7.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.8 | 7.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.8 | 8.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.6 | 23.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.5 | 13.8 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.5 | 4.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.5 | 1.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.4 | 4.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.4 | 4.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.4 | 4.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.3 | 5.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.3 | 6.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.3 | 6.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.2 | 6.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.2 | 3.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.1 | 3.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.1 | 3.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.1 | 5.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 2.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.0 | 3.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.0 | 3.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.0 | 4.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.0 | 7.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.0 | 21.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.9 | 2.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.9 | 1.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.9 | 6.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.9 | 4.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.9 | 4.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.9 | 2.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.9 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 4.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 25.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 2.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 2.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 3.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 8.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.8 | 7.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.8 | 7.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 2.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 2.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 6.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 3.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 4.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.7 | 4.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.7 | 2.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.7 | 6.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 2.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 2.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 5.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.7 | 3.3 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 4.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 2.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 1.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 4.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 0.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 1.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.6 | 1.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 2.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 1.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 2.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 0.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 2.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.6 | 1.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 7.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 8.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 18.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 1.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 3.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 2.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.5 | 2.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 1.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 5.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.5 | 3.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.5 | 1.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.5 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 3.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 2.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 1.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 1.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 1.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 4.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.5 | 2.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 14.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 2.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 1.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.5 | 5.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.5 | 1.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 1.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.5 | 1.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 7.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 2.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 27.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 1.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 1.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 2.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 1.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 2.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 1.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 2.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 4.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 2.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 10.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 5.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.4 | 2.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 5.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.4 | 10.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 2.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 4.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 5.7 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 2.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 0.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 1.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 4.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 6.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 3.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 1.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 4.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 8.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 2.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 1.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 1.9 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 6.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 1.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 13.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 2.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 1.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 0.6 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 0.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.9 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 1.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 0.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 2.8 | GO:0070990 | snRNP binding(GO:0070990) |
0.3 | 0.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.4 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.3 | 7.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.3 | 1.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 5.6 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.3 | 3.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 1.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 5.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 3.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 3.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 2.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 0.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 2.4 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 0.9 | GO:0034549 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 1.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 2.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 1.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 1.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 3.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 4.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 3.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 2.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.8 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 1.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 1.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 0.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 1.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 5.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 2.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 1.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 3.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 3.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 3.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 5.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 4.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.2 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 3.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.6 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 2.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.3 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 3.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.0 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 2.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 4.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 3.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 1.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 1.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 2.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 2.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.7 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 1.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 1.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 5.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 2.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 6.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 3.7 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 1.0 | GO:0034882 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 1.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 1.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 6.8 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.8 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.1 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 9.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 1.7 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.5 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 5.5 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.0 | 0.0 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 43.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.9 | 12.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 8.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 1.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.7 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 7.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 14.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 3.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 10.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 9.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 8.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 10.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 12.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 6.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 3.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 2.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 5.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 6.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 1.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 0.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 2.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 1.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 3.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 9.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 45.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.9 | 3.9 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
1.2 | 1.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.1 | 13.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 3.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 38.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 9.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 5.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.8 | 25.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 11.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.7 | 5.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.7 | 13.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.7 | 7.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 2.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.7 | 15.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 15.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.6 | 1.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.5 | 2.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.5 | 14.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 11.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 6.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 7.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 5.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 9.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 6.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 4.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 5.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 8.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.4 | 5.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 0.4 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.4 | 12.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 0.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 5.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 4.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 4.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 3.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 1.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 2.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 2.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 3.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 0.9 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.3 | 0.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 4.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 1.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.3 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 2.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 4.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 10.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 2.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 3.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 4.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 1.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 1.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 11.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 2.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 4.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 3.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 2.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.1 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 2.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.0 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 2.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |